| Appearance and Shape (20°C) | Solid |
|---|---|
| CAS RN | 57988-58-6 |
| MDL number | MFCD00067034 |
| Molecular weight | 256.14 |
| Molecular Formula | C11H14BrNO |
| Product code | ICTB1719 |
| PubChem Substance ID | 87564618 |
| Purity/Analytical Methods | >98.0%(GC)(T) |
| Reaxys-RN | 8550701 |
| SDBS (AIST Spectral DB) | 19634 |
| Appearance | White to Light yellow to Light orange powder to crystal |
|---|---|
| Purity(GC) | min. 98.0 % |
| Pictograms |
|
|---|---|
| Hazard statement | H315 : Causes skin irritation H319 : Causes serious eye irritation. |
| Precautionary Statements | P264 : Wash skin thoroughly after handling P280 : Wear protective gloves/ eye protection/ face protection P337 + P313 : If eye irritation persists: Get medical advice/ attention P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P302 + P352 : IF ON SKIN: Wash with plenty of soap and water P332 + P313 : If skin irritation occurs: Get medical advice/ attention P362 : Take off contaminated clothing and wash before reuse. |
| Signal word | Warning |
Chemistry Building Blocks Heterocyclic Building Blocks Halogenated Heterocyclic Building Blocks Piperidines [Halogenated Heterocyclic Building Blocks] Pharmaceutical Development and Drug Discovery Research Reagents Building Blocks for Pharmaceutical ingredients
Life Science Pharmaceutical Development and Drug Discovery Research Building Blocks for Pharmaceutical ingredients